Apothecon Pharma appoints Shyamakant Giri as Group CEO
In his new role, he will lead the growth strategy for the group’s operations, including Apothecon Pharmaceuticals in India and Navinta LLC in the United States
In his new role, he will lead the growth strategy for the group’s operations, including Apothecon Pharmaceuticals in India and Navinta LLC in the United States
New CE-marked algorithm for the Azurion platform delivers improved image quality with over 50% lower radiation dose compared to the lowest settings on ClarityIQ
The therapy is suited for patients with severe valve leakage who face elevated surgical risk due to advanced age, frailty, or multiple medical complications
The new facility at Byatarayanapura introduces Karnataka’s first Elekta Unity MR-Linac technology
The product has received tentative USFDA approval, Health Canada notice of compliance, and Indian regulatory approval
Collaboration with Siddhi Diagnostics combines genomics and advanced imaging capabilities to strengthen precision diagnostics in high-growth suburban markets
Initiative focuses on early diagnosis, gut health awareness and long-term gluten-free care for children with celiac disease
Despite the strong results, investigators cautioned that the study has limitations, including its open-label Phase II design, lack of randomization, and reliance on a historical external control arm
The deal also establishes a new subsidiary, Excellos Labs, which will oversee continued operations in San Diego
The global pharmaceutical company has been featured in both the DJBIC World Index and the DJBIC Emerging Markets Index
Subscribe To Our Newsletter & Stay Updated